Interleukin-23p19 Inhibitors in Inflammatory Bowel Disease: From Current Insights to Future Directions.
Saved in:
| Title: | Interleukin-23p19 Inhibitors in Inflammatory Bowel Disease: From Current Insights to Future Directions. |
|---|---|
| Authors: | Pool IA; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Otten AT; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Kosterink JGW; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Dijkstra G; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Mian P; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; Pharmacometrics Expertise Center of the Northern Netherlands, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; Department of Pharmaceutical, Technology and Biopharmacy, Groningen Research Institute of Pharmacy, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Bourgonje AR; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; The Dr. Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, 1468 Madison Avenue, New York, 10029 NY, USA. |
| Source: | Journal of personalized medicine [J Pers Med] 2026 Feb 14; Vol. 16 (2). Date of Electronic Publication: 2026 Feb 14. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101602269 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4426 (Print) Linking ISSN: 20754426 NLM ISO Abbreviation: J Pers Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2075-4426 |
|---|---|
| DOI: | 10.3390/jpm16020119 |
